legislation: 104-s-1277

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
104-s-1277 104 s 1277 Pharmaceutical Industry Special Equity Act of 1996 Commerce 1995-09-27 1996-10-01 Placed on Senate Legislative Calendar under General Orders. Calendar No. 640. Senate Sen. Brown, Hank [R-CO] CO R B000919 2 Pharmaceutical Industry Special Equity Act of 1996 - Declares that certain patent infringement remedies, as the term "patent" has been modified by the Uruguay Round Agreements Act (Uruguay Act), shall not apply to any patent if: (1) the patent is subject to certification under Federal Food, Drug, and Cosmetic Act (FDCA) provisions relating to new drug applications, abbreviated new drug applications, or abbreviated applications for new animal drugs; (2) after enactment of this Act, the certification is made in an application under such provisions accepted for filing before June 8, 1995; and (3) an unappealable final order has been made in an action under specified infringement of patent provisions, finding that the certifier made a substantial investment and establishing the amount of equitable remuneration to be paid by the certifier to the patentee. Declares that all patents in force on June 8, 1995, are entitled to the full benefit of the Uruguay Act and any extension granted before such date under certain patent provisions. Requires that, notwithstanding specified patent provisions, the term of a patent be extended for any patent that encompasses within its scope of composition of matter known as a nonsteroidal anti-inflammatory drug if certain circumstances exist. Expresses the sense of the Senate regarding the concluding of litigation under this Act. 2025-07-21T19:32:26Z  

Links from other tables